Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) Therapeutic Domains

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 10 Fastest Growing Mid Cap Stocks to Buy Now. ACADIA Pharmaceuticals ...

Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates

Acadia (ACAD) delivered earnings and revenue surprises of +31.36% and -2.94%, respectively, for the quarter ended December ...
Fintel on MSN

Wolfe Research initiates coverage of ACADIA Pharmaceuticals (ACAD) with outperform recommendation

Fintel reports that on February 24, 2026, Wolfe Research initiated coverage of ACADIA Pharmaceuticals (NasdaqGS:ACAD) with a ...

Forecasting The Future: 10 Analyst Projections For ACADIA Pharmaceuticals

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $32.7, a high estimate of $40.00, and a low estimate of $23.00. This upward trend ...
Benzinga.com

Acadia Pharmaceuticals (ACAD) Stock Explodes 26% After Patent Court Victory

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock jumped 26.6% to $22.29 on Friday afternoon following a favorable court ruling. What To Know: The U.S. District Court for the District of Delaware upheld ...
Nasdaq

GSK or ACAD: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Nasdaq

ACADIA Pharmaceuticals Inc. Common Stock (ACAD) Institutional Holdings

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...